Abstract
Protein S-palmitoylation mediated by DHHCs is recognized as a distinct and reversible form of lipid modification connected with several health perturbations, including neurodegenerative disorders, cancer, and autoimmune conditions. However, the pharmacological characteristics of current pan-DHHC inhibitors, particularly their toxicity and off-target effects, have hindered their in-depth cellular investigations. The therapeutic properties of the natural compounds, with minimal side effects, allowed us to evaluate them as DHHC-targeting inhibitors. Here, we performed an insilico screening of 115 phytochemicals to assess their interactions with the DHHC20 binding site. Among these compounds, lutein, 5-hydroxyflavone, and 6-hydroxyflavone exhibited higher binding energy (−9.2, −8.5, and −8.5 kcal/mol) in the DHHC20 groove compared to pan-DHHC inhibitor 2-BP (−7.0 kcal/mol). Furthermore, we conducted a 100 ns MD simulation to evaluate the stability of these complexes under physiological conditions. The MDsimulation results indicated that DHHC20 formed a more stable conformation with lutein compared to 5-hydroxyflavone and 6-hyroxyflavone via hydrophobic and H-bond interactions. Conclusively, these results could serve as a promising starting point for exploring the use of these natural molecules as DHHC20 inhibitors.
Communicated by Ramaswamy H. Sarma
Author contributions
S.C. collected the data and wrote the manuscript. N.P. edited the manuscript. S.S. and A.S. supported, managed, and supervised the manuscript.
Acknowledgment
We are thankful to all members of Sushabhan Sadhukhan and Avinash Sonawane laboratories for their valuable discussions.
Consent for publication
All authors approved the final manuscript for submission.
Disclosure statement
The authors declare no competing interest.